UTI Medium To Long Duration Growth Direct Plan
SIP amount
Min. ₹500
Lumpsum amount
Min. ₹500

UTI Medium To Long Duration Growth Direct Plan

NAV
₹75.7722
-0.05%
(22 Nov)
AUM
313 Cr
TER
1.24%
Risk
Moderate Risk
Rating
Insights
Net Asset Value (NAV) is above its 200 days moving average
Total Expense Ratio (TER) is in the top 25% of comparable funds
In beta. Send feedback here.
Compare with other fund
1Y
+10.2%
+9.3%
+9.1%
+9.0%
+9.0%
+8.6%
3Y
+6.6%
+6.6%
+6.6%
+8.3%
+6.5%
+5.7%
5Y
+6.2%
+6.9%
+7.2%
+7.3%
+7.6%
+5.9%
ALL
+7.2%
+8.1%
+8.2%
+6.9%
+8.2%
+6.3%
VOL
2.7%
3.7%
3.3%
4.9%
3.1%
-
TER
0.2%
0.7%
0.6%
1.2%
0.8%
-
AUM
₹180 Cr
₹395 Cr
₹2,959 Cr
₹313 Cr
₹1,805 Cr
-
INFO
2.61
2.17
2.50
1.41
2.61
-
Past performance
Past performance is no guarantee of future returns.
Had you invested
Over the last
1Y
3Y
ALL
Your returns would have been
UTI Medium To Long Duration (G)
₹1,00,00,00,000
14.0%
Fixed deposit
₹40,00,00,000
6.0%
Bank savings
₹40,00,00,000
3.0%
See fund holdings as of 15th Sep
Top holdings
7.18% Govt Stock 2037
51.4%
Power Finance Corporation Ltd. - NCD & Bonds - NCD & Bonds
8.1%
LIC Housing Finance Limited - NCD & Bonds - NCD & Bonds
8.1%
Hdb Financial Services Limited - NCD & Bonds - NCD & Bonds
8.0%
Jamnagar Utilities And Power Private Limited - NCD & Bonds - NCD & Bonds
6.5%
7.04% Govt Stock 2029
4.9%
Cholamandalam Investment And Finance Company Limited - NCD & Bonds - NCD & Bonds
4.8%
Net Current Assets
2.8%
07.78 RJ Sdl 2033
1.7%
07.74 MH Sgs 2033
1.7%
Other information
Minimum SIP
₹500
Minimum lumpsum
₹500
Additional lumpsum
₹500
Portfolio turnover
-
Lock-in period
-
Exit load
No exit load
Fund objective
The investment objective of the scheme is to generate optimal returns with adequate liquidity by investing in debt and money market instruments such that the Macaulay duration of the portfolio is between 4 years and 7 years. However there can be no assurance that the investment objective of the Scheme will be achieved. The Scheme does not guarantee / indicate any returns.
Fund manager(s)
Sunil Patil

FAQs